RT @MesenchymalCell: Drs. Sara Al-Khawaga & Essam Abdelalim (@AbdelalimEM) from Hamad Bin Khalifa University (@HBKU) summarize the immunopa…
RT @MesenchymalCell: Drs. Sara Al-Khawaga & Essam Abdelalim (@AbdelalimEM) from Hamad Bin Khalifa University (@HBKU) summarize the immunopa…
Drs. Sara Al-Khawaga & Essam Abdelalim (@AbdelalimEM) from Hamad Bin Khalifa University (@HBKU) summarize the immunopathogenesis of #SARS-CoV-2 and the therapeutic potentials of #MSCs for treating #lung injuries associated with #COVID-19. 🫁 @HMC_Qatar
RT @AbdelalimLab: Our recent review on the use of MSCs as a therapeutic option for the SARS-CoV-2 infection. @AbdelalimEM @HBKU @QF @HMC_Q…
Our recent review on the use of MSCs as a therapeutic option for the SARS-CoV-2 infection. @AbdelalimEM @HBKU @QF @HMC_Qatar #COVID__19 #clinicaltrials #StemCells https://t.co/FANRet2Ika